<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">

  <!-- ═══ CORE PAGES — highest revenue impact ═══ -->
  <url><loc>https://fairvaluex.com/</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>1.0</priority></url>
  <url><loc>https://fairvaluex.com/services</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.95</priority></url>
  <url><loc>https://fairvaluex.com/contact</loc><changefreq>monthly</changefreq><priority>0.90</priority></url>
  <url><loc>https://fairvaluex.com/methodology</loc><changefreq>monthly</changefreq><priority>0.85</priority></url>
  <url><loc>https://fairvaluex.com/proof</loc><changefreq>monthly</changefreq><priority>0.80</priority></url>
  <url><loc>https://fairvaluex.com/about</loc><changefreq>monthly</changefreq><priority>0.75</priority></url>
  <url><loc>https://fairvaluex.com/resources</loc><lastmod>2026-07-21</lastmod><changefreq>weekly</changefreq><priority>0.90</priority></url>
  <url><loc>https://fairvaluex.com/schedule</loc><changefreq>monthly</changefreq><priority>0.50</priority></url>

  <!-- ═══ PRACTICE-AREA PAGES — primary commercial landing pages ═══ -->
  <url><loc>https://fairvaluex.com/409a-valuation</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.95</priority></url>
  <url><loc>https://fairvaluex.com/asc-820-valuation</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.95</priority></url>
  <url><loc>https://fairvaluex.com/purchase-price-allocation</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.95</priority></url>
  <url><loc>https://fairvaluex.com/asc-718-valuation</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.95</priority></url>

  <!-- ═══ 409A ARTICLES — highest search volume, core revenue ═══ -->
  <url><loc>https://fairvaluex.com/articles/complete-guide-409a-valuations</loc><changefreq>monthly</changefreq><priority>0.90</priority></url>
  <url><loc>https://fairvaluex.com/articles/what-auditors-look-for-409a</loc><changefreq>monthly</changefreq><priority>0.88</priority></url>
  <url><loc>https://fairvaluex.com/articles/409a-triggering-events</loc><changefreq>monthly</changefreq><priority>0.85</priority></url>
  <url><loc>https://fairvaluex.com/articles/409a-safe-harbor-guide</loc><changefreq>monthly</changefreq><priority>0.83</priority></url>
  <url><loc>https://fairvaluex.com/articles/409a-audit-readiness-checklist</loc><changefreq>monthly</changefreq><priority>0.80</priority></url>
  <url><loc>https://fairvaluex.com/articles/409a-audit-support</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>
  <url><loc>https://fairvaluex.com/articles/409a-valuation-cost</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.88</priority></url>

  <!-- ═══ ASC 820 / PE FUND MARKS — institutional audience ═══ -->
  <url><loc>https://fairvaluex.com/articles/asc-820-fair-value-guide</loc><changefreq>monthly</changefreq><priority>0.88</priority></url>
  <url><loc>https://fairvaluex.com/articles/quarter-close-consistency</loc><changefreq>monthly</changefreq><priority>0.83</priority></url>
  <url><loc>https://fairvaluex.com/articles/wacc-risk-free-rates</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>
  <url><loc>https://fairvaluex.com/articles/scenario-modeling</loc><changefreq>monthly</changefreq><priority>0.75</priority></url>

  <!-- ═══ PPA / ASC 805 — M&A transaction audience ═══ -->
  <url><loc>https://fairvaluex.com/articles/purchase-price-allocation-guide</loc><changefreq>monthly</changefreq><priority>0.87</priority></url>
  <url><loc>https://fairvaluex.com/articles/ppa-audit-questions</loc><changefreq>monthly</changefreq><priority>0.82</priority></url>
  <url><loc>https://fairvaluex.com/articles/mpeem-vs-relief-from-royalty</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>
  <url><loc>https://fairvaluex.com/articles/customer-relationship-mpeem</loc><changefreq>monthly</changefreq><priority>0.75</priority></url>

  <!-- ═══ METHODOLOGY / DLOM — differentiation + SEO authority ═══ -->
  <url><loc>https://fairvaluex.com/articles/opm-vs-backsolve-vs-pwerm</loc><changefreq>monthly</changefreq><priority>0.85</priority></url>
  <url><loc>https://fairvaluex.com/articles/dlom-audit-target</loc><changefreq>monthly</changefreq><priority>0.83</priority></url>
  <url><loc>https://fairvaluex.com/articles/dlom-deep-dive</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>
  <url><loc>https://fairvaluex.com/articles/finnerty-model-dlom</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.85</priority></url>
  <url><loc>https://fairvaluex.com/articles/chaffe-model-dlom</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.85</priority></url>
  <url><loc>https://fairvaluex.com/articles/opm-backsolve-method</loc><lastmod>2026-07-21</lastmod><changefreq>monthly</changefreq><priority>0.85</priority></url>

  <!-- ═══ ASC 718 — stock compensation ═══ -->
  <url><loc>https://fairvaluex.com/articles/asc-718-private-companies</loc><changefreq>monthly</changefreq><priority>0.82</priority></url>
  <url><loc>https://fairvaluex.com/articles/asc-718-inputs-guide</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>
  <url><loc>https://fairvaluex.com/articles/asc-718-bsm-lattice-monte-carlo</loc><changefreq>monthly</changefreq><priority>0.75</priority></url>

  <!-- ═══ DOCUMENTATION / DEFENSIBILITY ═══ -->
  <url><loc>https://fairvaluex.com/articles/evidence-trail-design</loc><changefreq>monthly</changefreq><priority>0.83</priority></url>
  <url><loc>https://fairvaluex.com/articles/professional-judgment-documentation</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>
  <url><loc>https://fairvaluex.com/articles/reproducibility-standard</loc><changefreq>monthly</changefreq><priority>0.78</priority></url>

  <!-- terms/privacy intentionally omitted: they carry noindex -->

</urlset>
